pGAMA-YAP Citations (8)

Originally described in: YAP Induces Human Naive Pluripotency.
Qin H, Hejna M, Liu Y, Percharde M, Wossidlo M, Blouin L, Durruthy-Durruthy J, Wong P, Qi Z, Yu J, Qi LS, Sebastiano V, Song JS, Ramalho-Santos M Cell Rep. 2016 Mar 15;14(10):2301-12. doi: 10.1016/j.celrep.2016.02.036. Epub 2016 Mar 3. PubMed Journal

---

Articles Citing pGAMA-YAP

Articles
A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer. Zhao X, Wang X, Fang L, Lan C, Zheng X, Wang Y, Zhang Y, Han X, Liu S, Cheng K, Zhao Y, Shi J, Guo J, Hao J, Ren H, Nie G. Cancer Lett. 2017 Aug 28;402:61-70. doi: 10.1016/j.canlet.2017.05.015. Epub 2017 May 30. PubMed
Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents. Xu W, Chen C, Xu R, Li Y, Hu R, Li Z, Zhu X. Biomed Pharmacother. 2018 Jun;102:587-593. doi: 10.1016/j.biopha.2018.03.098. Epub 2018 Apr 5. PubMed
YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma. Shim J, Lee JY, Jonus HC, Arnold A, Schnepp RW, Janssen KM, Maximov V, Goldsmith KC. Cancer Res. 2020 Nov 1;80(21):4741-4753. doi: 10.1158/0008-5472.CAN-20-0025. Epub 2020 Sep 8. PubMed
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. Shields CE, Potlapalli S, Cuya-Smith SM, Chappell SK, Chen D, Martinez D, Pogoriler J, Rathi KS, Patel SA, Oristian KM, Linardic CM, Maris JM, Haynes KA, Schnepp RW. Mol Oncol. 2021 Feb 1. doi: 10.1002/1878-0261.12914. PubMed
Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition. Price CJ, Stavish D, Gokhale PJ, Stevenson BA, Sargeant S, Lacey J, Rodriguez TA, Barbaric I. Dev Cell. 2021 Sep 13;56(17):2455-2470.e10. doi: 10.1016/j.devcel.2021.07.019. Epub 2021 Aug 17. PubMed
Arp2/3 complex activity enables nuclear YAP for naive pluripotency of human embryonic stem cells. Meyer NP, Singh T, Kutys ML, Nystul TG, Barber DL. Elife. 2024 Sep 25;13:e89725. doi: 10.7554/eLife.89725. PubMed
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling. Nakagawa R, Beardsley A, Durney S, Hayward MK, Subramanyam V, Meyer NP, Wismer H, Goodarzi H, Weaver VM, Van de Mark D, Goga A. bioRxiv [Preprint]. 2025 Jan 31:2024.09.26.615226. doi: 10.1101/2024.09.26.615226. PubMed
Dynamic decoding of VEGF signaling and coordinated control of multiple phenotypes by the Src-TEM4-YAP pathway. Lee SH, Kang TY, Shang X, Levchenko A. Cell Syst. 2025 Jul 16;16(7):101321. doi: 10.1016/j.cels.2025.101321. Epub 2025 Jun 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.